Quick Summary
Covering the latest research from top Wall Street investment banks

Hong Kong/China insurance 1H26 earnings are expected to be strong, but a high 3Q base poses near-term pressure

Institution
Morgan Stanley
Date
2026-07-30
Authors
Rick Zhao, Richard Xu, CFA, Chenqian Liu
Company
-
Ticker
-
Industry
Hong Kong/China Insurance
Rating
Medium-term sector view remains Attractive; Ping An is the Top Pick, 2318.HK is Overweight; CPIC-A downgraded to Equal-weight.
NeutralLow confidence1H26 earnings and VNB are expected to be strong, investment income should benefit from A-share gains, and the P&C combined ratio should improve; however, a high 3Q base and expected selling by major shareholders create near-term valuation pressure.
AuthorsRick Zhao, Richard Xu, CFA, Chenqian Liu
Target pricePing An 2318.HK HK$88.00; Ping An 601318.SS Rmb79.00; CPIC 2601.HK HK$37.70; CPIC 601601.SS Rmb37.00.
CoverageAsia-Pacific
Asset classesEquity
Business segmentsLife insurance、P&C insurance、Banking、Asset management、FinTech
Research firm divisions/subsidiariesMorgan Stanley(Other)

AI summary card

Hong Kong/China insurance 1H26 earnings are expected to be strong, but a high 3Q base poses near-term pressure

Morgan Stanley believes the insurance sector's medium-term fundamentals remain attractive, with resilient 1H26 earnings, net assets and VNB, but uncertainty over shareholder selling and a high 3Q base limit near-term valuation re-rating.

Maintain a constructive medium-term view; preferences are more selective, with Ping An as the Top Pick; CPIC-A downgraded to Equal-weight after underperforming peers.
Hong Kong/China insurance1H26 earnings previewVNB growthP&C combined ratioShareholder selling pressurePing An Top Pick
  • A-share gains, particularly strength in the STAR market, are expected to boost insurers' investment income, leading Morgan Stanley to raise FY26E earnings forecasts for most insurers by 12%-68%.
  • Most insurers are still expected to deliver double-digit VNB growth in 1H26, led by China Life at approximately 32%, followed by AIA China at approximately 21%.
  • P&C operations continue to improve, with PICC P&C's 1H26 combined ratio expected to decline to approximately 94.5% and annualized ROE potentially exceeding 20%.
  • Valuation methodologies are mostly unchanged, but target prices are affected by temporary technical discounts: a 5% discount is applied to most A-share insurers, a 3% discount to most H-share insurers, and a higher discount to China Life A due to its lower free float.

Report interpretation

Overview

This report is Morgan Stanley's 1H26 earnings preview for the Hong Kong/China insurance sector. It concludes that insurers' 1H26 earnings, net assets and VNB should remain broadly resilient, benefiting from equity-market gains, improved business quality and continued insurance demand; however, the sector must absorb near-term valuation pressure from a high 3Q base, bancassurance regulatory disruptions and potential selling by major shareholders.

Core views

The key views are: first, 1H26 earnings should be strong, with China Life's earnings potentially increasing approximately 2.2x year on year, China Taiping Insurance Holdings' earnings rising approximately 91%, Ping An's net profit growing approximately 29% and OPAT approximately 8%; second, 1H26 VNB should remain healthy, although 2Q and 3Q growth may slow marginally due to a high base and bancassurance regulation; third, P&C combined ratios should continue to improve, with low catastrophe losses and expense discipline supporting underwriting quality; fourth, the industry's medium- to long-term logic remains intact, including improving profitability, better business quality and sustained demand, but near-term catalysts for valuation re-rating are limited.

Analysis framework

The report compares major insurers using 1H26 forecasts for earnings, VNB, EV, BV, DPS and P&C combined ratios, and provides rankings and target prices based on fundamental forecast revisions, valuation methodology updates, shareholder-selling scenario discounts and a risk-reward framework.

Methodology notes

  • Valuation methodsThree-stage dividend discount model

    DDM

    The base case for H-share insurers primarily uses a three-stage dividend discount model, valuing companies based on dividend payout ratios, dividend growth rates, cost of capital and terminal growth rates across different stages.

  • Valuation methodsP/EV, P/BV and SOTP

    P/EV, P/BV, SOTP

    P/EV is used for A-share life insurers, P/BV for property and casualty insurers, and SOTP for diversified financial groups such as Ping An, CPIC and PICC Group.

  • scenario_analysisBull/Base/Bear cases

    Bull/Base/Bear case

    The bull case assumes improving equity markets and interest-rate conditions, the bear case assumes low interest rates and pressure on the value of in-force life insurance business, while the base case reflects stable rates, markets and fundamental recovery.

  • technical_adjustmentTemporary shareholder-selling discount

    shareholder overhang discount

    The report applies temporary valuation discounts for potential selling pressure from major shareholders: generally 5% for A shares and 3% for H shares, with a higher discount for China Life A due to its lower free float.

Asset mapping & comparison

Structured mapping from thesis to named assets (strengths, weaknesses, peers, risks).

  • Ping An Insurance Group Co of China Ltd 2318.HK / 601318.SS
    Top Pick; Overweight
    Strengths
    De-risking is entering its later stages, OPAT trends are resilient, core life insurance growth is healthy, and it has competitive advantages in integrated finance, healthcare and retirement, and AI applications, with a dividend yield of approximately 6%.
    Weaknesses
    The asset management business may still be a short-term drag, while quarterly VNB growth may face greater scrutiny.
    Comparison
    Compared with most life insurance peers, it has an easier 3Q base and more resilient OPAT, and is expected to demonstrate greater resilience.
    Risks
    Equity-market and interest-rate volatility, low interest rates or asset/real-estate risks, shareholder-selling pressure, and capital levels and DPS below expectations.
  • China Life Insurance Co Ltd 2628.HK / 601628.SH
    Beneficiary of strong 1H26 earnings and VNB growth
    Strengths
    1H26 earnings are expected to rise approximately 2.2x year on year, with VNB growth of approximately 32%, the strongest among peers.
    Weaknesses
    A high 3Q base may create near-term growth resistance, while the valuation discount assumption for China Life A is relatively high.
    Comparison
    Growth leads in 1H26, but the stock is more affected in the near term by the high base and free-float ratio.
    Risks
    Slower 3Q growth, shareholder-selling expectations and an equity-market correction.
  • PICC P&C Company Ltd 2328.HK
    Defensive beneficiary
    Strengths
    The 1H26 combined ratio is expected to be approximately 94.5%, annualized ROE is expected to exceed 20%, valuation is approximately 1.0x 2026E P/B and the dividend yield is above 5%.
    Weaknesses
    1H26 premium growth is expected to be only approximately 2%-7%, with subdued auto premiums and slower government-related business.
    Comparison
    Compared with life insurers, it has an easier 3Q base and stronger defensive characteristics.
    Risks
    Higher catastrophe losses in 3Q and failure to meet the full-year combined-ratio target.
  • China Pacific Insurance Group Co Ltd 2601.HK / 601601.SS
    H-share target price HK$37.70; A shares downgraded to Equal-weight
    Strengths
    Valuation is below 0.8x 2026E P/B, with benefits from an equity-market rebound and sector rotation.
    Weaknesses
    1H26 earnings and VNB performance may lag major peers.
    Comparison
    Growth momentum is weaker than that of China Life, Ping An and some other peers.
    Risks
    Relative underperformance versus peers, slower VNB growth and shareholder-selling pressure.
  • PICC Group 1339.HK / 601319.SH
    Low-valuation insurance group
    Strengths
    With higher equity exposure, earnings growth may exceed that of PICC P&C; valuation is approximately 0.6x 2026E P/B.
    Weaknesses
    P&C accounts for a relatively high proportion of the business mix, and the terminal growth assumption is low.
    Comparison
    Its lower valuation provides upside sensitivity to equity-market performance and fair-value gains related to the CXMT listing.
    Risks
    Equity-market volatility, P&C underwriting risks and a weaker-than-expected valuation recovery.
  • China Taiping Insurance Holdings Co Ltd O966.HK
    Stock with strong 1H26 earnings growth
    Strengths
    1H26 earnings growth is expected to exceed that of most peers, with valuation at approximately 0.7x 2026E P/B.
    Weaknesses
    VNB growth may be lower than that of some core peers.
    Comparison
    Strong earnings may attract greater market attention before the end of August.
    Risks
    VNB growth below expectations and an equity-market decline.
  • New China Life Insurance Company Ltd 1336.HK / 601336.SH
    Healthy growth but less attractive valuation
    Strengths
    1H26 earnings and VNB growth are expected to remain healthy.
    Weaknesses
    Valuation is not sufficiently attractive, and the 3Q26 base is relatively high.
    Comparison
    Compared with other life insurers, its near-term risk-reward profile is not compelling.
    Risks
    Pressure from a high 3Q base, valuation correction and equity-market volatility.

Key data

  • China Life 1H26E earnings growthApproximately 2.2x year on yearThe report expects China Life to lead peers in earnings and VNB growth.
  • China Life 1H26E VNB growth32%Expected to lead among major insurers.
  • AIA China 1H26E VNB growth21%Listed by the report as one of the companies with strong VNB growth.
  • Ping An 1H26E earnings growthNet profit approximately +29%, OPAT approximately +8%Valued at approximately 0.8x 2026E P/B, with a dividend yield of approximately 6%.
  • PICC P&C 1H26E combined ratioApproximately 94.5%Improvement is driven by low catastrophe losses and expense discipline, with annualized ROE expected to exceed 20%.
  • FY26E earnings forecast adjustmentsRaised by 12%-68% for most insurersMainly reflects gains in the equity market during 1H26.
  • FY26E VNB forecast adjustmentsCut by 1%-5% for most insurersReflects a slowdown in the bancassurance channel amid tighter regulation.
  • Valuation discount assumptionsGenerally 5% for A shares, 3% for H shares, and 6% for China Life AUsed to reflect the technical impact of potential selling pressure from national-team holdings.

Impact & implications

The investment implication is that medium-term fundamentals still support sector exposure, but investors should be more selective in the near term: strong earnings expectations may support performance in August, while September and October are likely to be more defensive amid a high 3Q base. Ping An is the Top Pick due to its valuation, dividend yield, de-risking progress and relative 3Q resilience; PICC P&C offers defensive characteristics; CPIC is inexpensive but its growth may lag peers.

Risks

  • A high 3Q26 base causes a temporary slowdown in earnings and VNB growth.
  • Continued selling by national-team or major shareholders creates technical valuation and market-sentiment pressure.
  • Equity-market volatility affects investment income, net assets and fair-value changes.
  • A low interest-rate environment pressures life insurance spreads and embedded-value assumptions.
  • Tighter regulation of the bancassurance channel slows VNB growth and new-business sales.
  • P&C operations face the risk of higher catastrophe losses and a deterioration in the combined ratio.

What to watch

  • The official 1H26 earnings release dates and whether earnings, OPAT and VNB meet expectations.
  • The resilience of each company's VNB and earnings growth in 3Q26 against a high base.
  • Changes in national-team holdings and whether market expectations of selling pressure ease.
  • The impact of A-share and STAR-market performance on investment income and net assets.
  • The impact of bancassurance regulatory policies on channel sales, FYP and margins.
  • PICC P&C's execution against its full-year combined-ratio target and 3Q catastrophe losses.
Zhejiang ICP No. 2022035445-5
Disclaimer: Market data, charts, indicators, research views, and other information provided on this website are intended solely for information display, research communication, and educational reference. They should not be regarded as personalized investment advice, securities recommendations, trading instructions, solicitations, or guarantees of return. While we strive to improve the reliability of our data and content, such information may still be subject to delays, errors, incompleteness, or untimely updates due to source differences, methodological limitations, system processing, or market volatility. Users should exercise independent judgment based on their own circumstances and bear all risks and responsibilities arising from the use of this website.

Settings

Sign in to view recent logins